Lynn Bodarky

Lynn Bodarky has a strong background in business development and alliance management within the pharmaceutical industry. Lynn is currently serving as the Chief Business Officer at Actinium Pharmaceuticals, Inc. Prior to their current role, Lynn held positions at several other pharmaceutical companies including HiFiBiO Therapeutics, Geron Corporation, and Intrexon Corporation. Lynn also served as President of LMB Consulting, LLC. Lynn's experience spans over 20 years, with roles in various senior leadership positions within global product access, public sector investment, and global licensing. Lynn'sexpertise and experience make their a valuable asset in the pharmaceutical industry.

Lynn Bodarky has a B.S. degree in Accounting/Finance from The Wharton School. Lynn also holds an MBA degree in Finance/International Business from Columbia Business School.